tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

MedPlus Subsidiary Faces Drug License Suspensions in Karnataka

Story Highlights
MedPlus Subsidiary Faces Drug License Suspensions in Karnataka

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

MedPlus Health Services Ltd. ( (IN:MEDPLUS) ) just unveiled an update.

MedPlus Health Services Ltd. announced that its subsidiary, Optival Health Solutions Private Limited, has received suspension orders for drug licenses at two of its stores in Karnataka. The suspensions, issued by the Drugs Control Administration, are expected to result in a potential revenue loss of approximately Rs 1.06 lacs, impacting the company’s financial operations in the region.

More about MedPlus Health Services Ltd.

MedPlus Health Services Ltd. operates in the healthcare industry, primarily focusing on providing pharmaceutical products and health services. The company is known for its extensive network of retail pharmacies across India, catering to a wide range of healthcare needs.

Average Trading Volume: 23,141

Technical Sentiment Signal: Buy

Current Market Cap: 100.7B INR

For detailed information about MEDPLUS stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1